EP3703710
Aðferðir og samsetningar til lyfjagjafar á ósamgena blendings mótefnavaka viðtaka T-frumum til meðhöndlunar á andstæðu og/eða bakslags B-stórfrumueitilæxli eða andstæðu og/eða bakslags hnútóttu eitilæxli sem er ekki Hodgkins-sjúkdómur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.10.2018EP published:
7.8.2024EP application number:
18804466.3
EP translation filed:
30.9.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
29.10.2038Expiry date:
29.10.2026Next due date:
31.10.2026
Title in English:
METHODS AND COMPOSITIONS FOR DOSING OF ALLOGENEIC CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TREATING REFRACTORY AND/OR RELAPSED LARGE B-CELL LYMPHOMA OR REFRACTORY AND/OR RELAPSED FOLLICULAR LYMPHOMALanguage of the patent:
English
Timeline
Today
30.10.2018EP application
7.8.2024EP Publication
30.9.2024Translation submitted
15.11.2024Registration published
29.10.2026Expires
Owner
Name:
Allogene Therapeutics, Inc.Address:
210 E. Grand Avenue, South San Francisco, CA 94080, US
Name:
Les Laboratoires ServierAddress:
35, rue de Verdun, 92284 Suresnes Cedex, FR
Inventor
Name:
KONTO, Cyril AlkisAddress:
South San Francisco California 94080, US
Name:
ZINAI, AminaAddress:
92284 Suresnes Cedex, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762579426 PDate:
31.10.2017Country:
US
Number:
201862716898 PDate:
9.8.2018Country:
US
Number:
201862750215 PDate:
24.10.2018Country:
US
Classification
Categories:
A61K 35/17, A61K 39/395, C07K 14/725, C12N 5/0783, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 25.11.2024
Expires: 29.10.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.10.2025
Expires: 29.10.2026
Payer: Árnason Faktor ehf.